Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Review Article

Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?

Author(s): Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem and Sherief Abd-Elsalam*

Volume 21, Issue 8, 2021

Published on: 04 January, 2021

Article ID: e160921189886 Pages: 4

DOI: 10.2174/1871526520666210104152256

Price: $65

Abstract

In late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic of the 21st century. It seems that this infection will persist which is long enough to obligate modifications in both lifestyle and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shed light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.

Keywords: Coronavirus disease, COVID-19, pandemic, chronic liver diseases, cirrhosis, HCC.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy